| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/20/2001 | EP0726765B1 Apparatus and method for preparing solid forms with controlled release of the active ingredient |
| 06/20/2001 | EP0686037B1 Hormone replacement therapy |
| 06/20/2001 | CN1300280A Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 06/20/2001 | CN1300220A Peptide compositions and formulations and use of same |
| 06/20/2001 | CN1300216A Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts of hydrates |
| 06/20/2001 | CN1300215A Preventives/remedies for skin diseases |
| 06/20/2001 | CN1300214A Composition comprising acarnitine and glutathione, useful to incrense the absorption of glutathione and synergize its effects |
| 06/20/2001 | CN1300213A Gamma-contained aminobutyric acid derivatives solid compositions and preparation process thereof |
| 06/20/2001 | CN1300208A Icecream-type pharmaceutical formulation and process for preparing the same |
| 06/20/2001 | CN1299682A Interferon spray |
| 06/20/2001 | CN1299673A Preparation of cancer treating medicine capsule |
| 06/20/2001 | CN1299670A Plaster and its preparation |
| 06/20/2001 | CN1299668A Multifunctional calcium tablet and its production process |
| 06/20/2001 | CN1299657A American ginseng-nucleic acid buccal tablet |
| 06/20/2001 | CN1299651A Dressing for treating infantile bronchitis and pulmonitis and its preparation |
| 06/20/2001 | CN1299650A Oral capsule and paster for treating ischemic femur head necrosis and their preparation |
| 06/20/2001 | CN1299645A Preparation of initially release-limiting granule |
| 06/20/2001 | CN1299623A Beauty hood |
| 06/20/2001 | CN1067410C Improved preparation method for biodegradable polymeric microspheres using solvent extraction and preparation method for microspheres for treating local inflammation using same |
| 06/20/2001 | CN1067277C Chewing medicinal piece of qi ju dihuang wan and prepe method thereof |
| 06/20/2001 | CN1067269C Shenmei soft and hard capsule |
| 06/20/2001 | CN1067264C Medicinal patch for treatment of cough and asthma |
| 06/20/2001 | CN1067263C Xiaoaisan powder for curing cancer |
| 06/20/2001 | CN1067259C Burns curing cream |
| 06/20/2001 | CN1067255C Fragrant drug steam |
| 06/20/2001 | CN1067251C Ointment for treatment of burns |
| 06/20/2001 | CN1067249C Medicine for treating asthma and its preparation method |
| 06/20/2001 | CN1067244C Notoginsenoside powder injection |
| 06/20/2001 | CN1067242C Production of beta-form thiamine hydrochloride crystals and tablets made from same |
| 06/20/2001 | CN1067241C Method for producing injection used for curing fowls and animals dysentery and diarrhea |
| 06/20/2001 | CN1067240C Medicinal plaster stroma |
| 06/19/2001 | US6248841 Using 2-mercaptoethanol |
| 06/19/2001 | US6248779 Synergistic mixture of vitamin e and squalane |
| 06/19/2001 | US6248771 Formulations for hydrophobic pharmaceutical agents |
| 06/19/2001 | US6248763 Psoriasis |
| 06/19/2001 | US6248760 Tablet giving rapid release of nicotine for transmucosal administration |
| 06/19/2001 | US6248758 Pharmaceutical antacid |
| 06/19/2001 | US6248727 Systemically administered diagnostic reagent for visualizing and occluding a blood vessel in a mammal comprising a liposome-encapsulated fluorescent dye releaseable at body temperature, a tissue reactive agent and a carrier |
| 06/19/2001 | US6248722 Topically administering a dosage of an expression vector containing hepatocyte growth factor (hgf) gene; gene therapy with reduced side effects |
| 06/19/2001 | US6248720 Method for gene therapy using nucleic acid loaded polymeric microparticles |
| 06/19/2001 | US6248391 Mixing primary film-former comprising dextrose, auxiliary film-former, sodium citrate and titanium dioxide into water to form aqueous coating dispersion, applying dispersion onto substrates, drying white film coating |
| 06/19/2001 | US6248390 Fiber-water—water containing soluble fiber |
| 06/19/2001 | US6248386 Extrusion a sweetening; applying vacuum |
| 06/19/2001 | US6248378 Expelling liquid; forming liquid-gas interface; fineness, uniform particle sizes |
| 06/19/2001 | US6248375 Food bar |
| 06/19/2001 | US6248363 Improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutraceuticals, cosmeceuticals and diagnostic agents |
| 06/19/2001 | US6248362 Core containing active material; interior layer of chitosan; overcaoting of zein |
| 06/19/2001 | US6248361 Water-soluble folic acid compositions |
| 06/19/2001 | US6248360 Complexes to improve oral absorption of poorly absorbable antibiotics |
| 06/19/2001 | US6248359 Sustained release |
| 06/19/2001 | US6248358 Bioadhesive progressive hydration tablets and methods of making and using the same |
| 06/19/2001 | US6248357 Mixture of erythritol, cellulose and disintegrant |
| 06/19/2001 | US6248355 Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation |
| 06/19/2001 | US6248354 Containing retinoid agent |
| 06/19/2001 | US6248353 Reconstitution of purified membrane proteins into preformed liposomes |
| 06/19/2001 | US6248350 Antiinflammatory analgesic patch |
| 06/19/2001 | US6248348 Incorporating poly-N-vinly amide in a transdermal system |
| 06/19/2001 | US6248346 Chewing gum and production of the same |
| 06/19/2001 | US6248345 Prolonged anesthesia in joints and body spaces |
| 06/19/2001 | US6248335 Ph control |
| 06/19/2001 | US6248308 Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma |
| 06/19/2001 | US6248307 Compositions and treatment for alleviation of symptoms associated with menopause |
| 06/19/2001 | US6248057 Absorbable brachytherapy and chemotherapy delivery devices and methods |
| 06/19/2001 | CA2172187C Method of incorporating drugs into a polymer component of stents |
| 06/19/2001 | CA2038577C Utilization and delivery of enzymes |
| 06/19/2001 | CA2027351C Emulsion of lipid containing a prostaglandin analogue |
| 06/19/2001 | CA1341260C Pharmaceutical and/or dietary compsitions containing l-carnitine and l- lysine |
| 06/19/2001 | CA1341259C Particle vector useful as a carrier of biologically active molecules, and a fabrication method |
| 06/14/2001 | WO2001042424A2 Sphingolipid-containing cationic liposomes for topical delivery of bioactive material |
| 06/14/2001 | WO2001042270A1 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions |
| 06/14/2001 | WO2001042255A1 (1R,CIS)-4-(4-AMINO-7H-PYRROLO'2,3-I(D) ! PYRIMIDINE-7-YL)-2-CYCLOPENTENE-1-METHANOL DERIVATIVES AS ANTIVIRAL |
| 06/14/2001 | WO2001042231A2 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors |
| 06/14/2001 | WO2001042225A2 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 06/14/2001 | WO2001042222A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | WO2001042221A1 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001041909A1 Compositions including ether-capped poly(oxyalkylated) alcohol wetting agents |
| 06/14/2001 | WO2001041822A1 Mineral-polymer hybrid composition |
| 06/14/2001 | WO2001041821A1 Mineral-polymer hybrid composition |
| 06/14/2001 | WO2001041810A2 Nucleic acid delivery system |
| 06/14/2001 | WO2001041809A1 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus |
| 06/14/2001 | WO2001041807A2 Transmucosal composition containing a phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 06/14/2001 | WO2001041806A1 Ophthalmic compositions |
| 06/14/2001 | WO2001041800A2 Compositions and methods for stabilizing biological molecules upon lyophilization |
| 06/14/2001 | WO2001041793A1 A stable aqua formulation of interferon, the preparation method and the uses thereof |
| 06/14/2001 | WO2001041789A1 Rheumatism remedy containing tetrapeptide derivative as active ingredient |
| 06/14/2001 | WO2001041788A1 INDUCING CELLULAR IMMUNE RESPONSES TO p53 USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
| 06/14/2001 | WO2001041785A2 Enzyme treatment for infection |
| 06/14/2001 | WO2001041776A2 Use of honey in medical dressings |
| 06/14/2001 | WO2001041775A2 Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response |
| 06/14/2001 | WO2001041772A1 Galenical preparations of dapsone and related sulphones, and method of therapeutic and preventative treatment of disease |
| 06/14/2001 | WO2001041771A2 Transdermal system containing acetylsalicylic acid for treatment of migraine |
| 06/14/2001 | WO2001041770A2 Nanoparticulate eplerenone compositions |
| 06/14/2001 | WO2001041765A1 Compositions containing itraconazole with improved bioavailability and narrow intra- and inter-individual variation of its absorption |
| 06/14/2001 | WO2001041762A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041761A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041760A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | WO2001041758A2 Valnemulin formulation |
| 06/14/2001 | WO2001041757A1 Cyclodextrin-containing pharmaceutical composition |
| 06/14/2001 | WO2001041753A2 Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds |
| 06/14/2001 | WO2001041746A1 Anti itch patch |